146.77
price down icon0.10%   -0.111
 
loading

Krystal Biotech Inc Azioni (KRYS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
8.91%
96.04
88.18 83.84 70.28 45.25
Operating Expenses
9.09%
56.73
52.01 61.41 61.72 51.93
Benefits Costs and Expenses
10.50%
49.27
44.59 54.07 54.24 -
Costs And Expenses
10.50%
49.27
44.59 54.07 54.24 51.93
Operating Income/Loss
8.65%
39.31
36.18 22.43 8.566 -6.684
Income/Loss From Continuing Operations Before Tax
7.29%
46.77
43.60 29.77 16.05 0.932
Income Tax Expense/Benefit
7.35%
8.442
7.864 2.589 0.477 -
Income/Loss From Continuing Operations After Tax
7.28%
38.33
35.73 27.18 15.57 0.932
Net Income/Loss
7.28%
38.33
35.73 27.18 15.57 0.932
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.33%
28.91
28.82 28.72 28.60 28.30
Diluted Average Shares
0.41%
29.75
29.87 29.90 29.64 29.29
Basic Earnings Per Share
7.26%
1.33
1.24 0.95 0.54 0.03
Diluted Earnings Per Share
7.50%
1.29
1.20 0.91 0.53 0.03
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.65
price up icon 0.39%
$84.63
price up icon 0.77%
$24.70
price down icon 8.71%
$103.63
price down icon 0.75%
$132.90
price up icon 0.26%
biotechnology ONC
$299.55
price down icon 2.91%
Capitalizzazione:     |  Volume (24 ore):